Envisagenics is an innovative biotechnology company leveraging its AI platform, SpliceCore®, to discover novel therapeutic targets in RNA splicing, focusing on oncology and neurodegenerative diseases
Envisagenics is an innovative biotechnology company leveraging its AI platform, SpliceCore®, to discover novel therapeutic targets in RNA splicing, focusing on oncology and neurodegenerative diseases.